University of Wisconsin–Madison researchers targeting a group of hereditary neurodegenerative diseases have found success ...

UW–Madison researchers used gene therapy to prevent hereditary spastic paraplegia (HSP) in a rat model, introducing a healthy ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

Sessions that focused on diagnosis and acute treatment of rare neuroimmune disorders (RNDs). A panel of people with these ...

Researchers have found that repetitive transcranial magnetic stimulation (rTMS) can efficiently reduce the symptoms of ...

The platform presentation entitled, “The MSA Atrophy Index: A Marker of Clinical Progression in Multiple System Atrophy”, was presented by Paula Trujillo Diaz, PhD, Research Assistant Professor, ...

America is becoming a third-world mess because we are being run by the very same foreign elites who run the third world, who know nothing except a shoddy secondhand Marxism and who are animated by pet ...

Neuronetics (STIM) delivered earnings and revenue surprises of -26.09% and 3.79%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Here are five possible reasons why your body may be reluctant to move: If you don't exercise often, your body may be unaccustomed to physical activity, making movement feel more ... for effective ...

Third quarter results highlight strong operational performance across key value drivers: YUPELRI® (revefenacin) net sales of $62.2 million, recognized by Viatris ...